Naltrexon Hydrochloride Accord (Naltrexone Hydrochloride)

Naltrexone hydrochloride competitively binds to mu, kappa and delta opioid receptors without activating them. This antagonism blocks the effects of endogenous opioids and exogenous opioid drugs, diminishing the reinforcing and euphoric sensations that drive alcohol and opioid use.

The specific dose and dosing schedule of Naltrexon Accord are determined by the prescribing clinician based on the patient’s condition, treatment goals and clinical response. Healthcare professionals tailor the regimen to each individual.

Safety data for naltrexone hydrochloride in pregnancy and lactation are limited. The prescriber must evaluate the potential benefits against possible risks to the fetus or infant before initiating therapy in pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naltrexon Accord’s active ingredient, naltrexone, is the most widely used oral opioid antagonist. Compared with injectable formulations such as naloxone, naltrexone provides a longer duration of receptor blockade, making it suitable for maintenance therapy, whereas naloxone is primarily used for acute opioid overdose reversal.

Store Naltrexon Accord at room temperature, below 25 °C, in the original packaging. Keep the product away from moisture, direct sunlight and sources of heat to maintain its stability.

Naltrexon Accord is taken orally, usually with water. The tablet should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include hepatotoxicity, which may present as elevated liver enzymes or liver injury, and severe allergic reactions such as rash, angioedema or anaphylaxis. Patients should be monitored for signs of liver dysfunction and hypersensitivity.

Naltrexon Accord is contraindicated in individuals with acute hepatitis, severe liver impairment, or those currently dependent on opioids who require analgesia. It should also be used with caution in patients with renal insufficiency and those with known hypersensitivity to naltrexone.